Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Otsuka Holdings Co's share price for the quarter that ended in Dec. 2024 was 円8600. Otsuka Holdings Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 537 Mil. Therefore, Otsuka Holdings Co's market cap for the quarter that ended in Dec. 2024 was 円4,619,000 Mil.
Otsuka Holdings Co's quarterly market cap
increased
from Jun. 2024 (円3,675,460 Mil) to Sep. 2024 (円4,368,271 Mil) and
increased
from Sep. 2024 (円4,368,271 Mil) to Dec. 2024 (円4,619,000 Mil).
Otsuka Holdings Co's annual market cap
increased
from Dec. 2022 (円2,336,039 Mil) to Dec. 2023 (円2,870,266 Mil) and
increased
from Dec. 2023 (円2,870,266 Mil) to Dec. 2024 (円4,619,000 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Otsuka Holdings Co's Enterprise Value for Today is 円3,854,034 Mil.
Otsuka Holdings Co Market Cap Historical Data
The historical data trend for Otsuka Holdings Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Otsuka Holdings Co's Market Cap
For the Drug Manufacturers - General subindustry, Otsuka Holdings Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Otsuka Holdings Co's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Otsuka Holdings Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Otsuka Holdings Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Otsuka Holdings Co's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Otsuka Holdings Co (TSE:4578) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Otsuka Holdings Co Market Cap Related Terms
Thank you for viewing the detailed overview of Otsuka Holdings Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Otsuka Holdings Co Ltd is a Japan-based company operates in pharmaceuticals, nutraceuticals and consumer products. Business activity of the company includes providing healthcare solutions in the areas of nervous system, oncology, cardiovascular system, respiratory system, infectious disease and others. It is also engaged in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks and dietary food. In addition it also operates multiple businesses related to chemicals, transportation, warehousing, and electronic equipment. Geographically, it operates in Japan, North America and in other regions of which Japan accounts for larger share of revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4578 has been successfully added to your 